LOBE — Lobe Sciences Balance Sheet
0.000.00%
Last trade - 00:00- CA$10.72m
- CA$5.05m
- CA$0.14m
- 41
- 14
- 59
- 30
Annual balance sheet for Lobe Sciences, fiscal year end - August 31st, CAD millions except per share, conversion factor applied.
2020 August 31st | 2021 August 31st | 2022 August 31st | 2023 August 31st | 2024 August 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Short Term Investments | 0.172 | 1.14 | 0.908 | 0.14 | 0.238 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 0.621 | 1.76 | 0.018 | 0.015 | 0.009 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 1.17 | 9.67 | 1.04 | 0.319 | 0.259 |
| Net Property, Plant And Equipment | 0.571 | 0 | — | — | — |
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 13 | 12.1 | 1.75 | 2.3 | 0.259 |
| Accounts Payable | |||||
| Payable / Accrued | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 0.777 | 0.805 | 1.3 | 2.46 | 2.27 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Liabilities | 0.897 | 0.805 | 1.3 | 2.46 | 3.37 |
| Common Stock | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 12.1 | 11.3 | 0.446 | -0.16 | -3.11 |
| Total Liabilities & Shareholders' Equity | 13 | 12.1 | 1.75 | 2.3 | 0.259 |
| Total Common Shares Outstanding |